John R. Lowe

1.0k total citations
26 papers, 794 citations indexed

About

John R. Lowe is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, John R. Lowe has authored 26 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Immunology. Recurrent topics in John R. Lowe's work include Cholinesterase and Neurodegenerative Diseases (7 papers), Pesticide Exposure and Toxicity (5 papers) and Bacteriophages and microbial interactions (4 papers). John R. Lowe is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (7 papers), Pesticide Exposure and Toxicity (5 papers) and Bacteriophages and microbial interactions (4 papers). John R. Lowe collaborates with scholars based in United States, Switzerland and France. John R. Lowe's co-authors include Susan L. Welkos, James J. Schmidt, Michael H. Vodkin, S H Leppla, Stephen F. Little, Claire N. Lieske, Valerie Quarmby, Maurício Maia, Jihong Yang and Jacques Gaudreault and has published in prestigious journals such as Analytical Biochemistry, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

John R. Lowe

26 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Lowe United States 14 478 207 170 142 121 26 794
Ten‐Yang Yen United States 17 743 1.6× 96 0.5× 91 0.5× 116 0.8× 54 0.4× 36 1.1k
Allan Rosenthal United States 12 307 0.6× 73 0.4× 101 0.6× 41 0.3× 212 1.8× 17 672
Michael E. Hudson United States 8 555 1.2× 121 0.6× 59 0.3× 120 0.8× 10 0.1× 15 923
Brandi Levin United States 12 443 0.9× 41 0.2× 307 1.8× 132 0.9× 6 0.0× 20 939
T D Heath United Kingdom 8 367 0.8× 106 0.5× 41 0.2× 121 0.9× 22 0.2× 9 603
Mireille Cartier Canada 13 485 1.0× 33 0.2× 87 0.5× 61 0.4× 14 0.1× 17 826
Anna Lucia Tornesello Italy 13 727 1.5× 93 0.4× 64 0.4× 186 1.3× 5 0.0× 24 1.1k
Raquel García-Castellanos Spain 14 293 0.6× 26 0.1× 115 0.7× 79 0.6× 8 0.1× 21 569
Theodoros Goulas Spain 18 456 1.0× 39 0.2× 109 0.6× 79 0.6× 8 0.1× 34 901
Vanesa Olivares‐Illana Mexico 20 667 1.4× 18 0.1× 80 0.5× 43 0.3× 40 0.3× 37 1.1k

Countries citing papers authored by John R. Lowe

Since Specialization
Citations

This map shows the geographic impact of John R. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Lowe more than expected).

Fields of papers citing papers by John R. Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Lowe. The network helps show where John R. Lowe may publish in the future.

Co-authorship network of co-authors of John R. Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Lowe. A scholar is included among the top collaborators of John R. Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Lowe. John R. Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lowe, John R., et al.. (2018). Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum. Journal of Immunological Methods. 461. 44–52. 11 indexed citations
2.
Fischer, Saloumeh K, Melissa Cheu, Kun Peng, et al.. (2016). Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material. The AAPS Journal. 19(1). 254–263. 85 indexed citations
3.
4.
Qiu, Zhihua, Yong Ying, Michael Fox, et al.. (2010). A novel homogeneous Biotin–digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum. Journal of Immunological Methods. 362(1-2). 101–111. 21 indexed citations
5.
Lowe, John R., Maurício Maia, Eric Wakshull, et al.. (2010). Development of a novel homogenous electrochemiluminescence assay for quantitation of ranibizumab in human serum. Journal of Pharmaceutical and Biomedical Analysis. 52(5). 680–686. 10 indexed citations
6.
Finco, Deborah, Daniel Baltrukonis, Adrienne Clements‐Egan, et al.. (2010). Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics. Journal of Pharmaceutical and Biomedical Analysis. 54(2). 351–358. 29 indexed citations
7.
Loveless, Bonnie M., David Norwood, David M. Waag, et al.. (2009). Real-time PCR for the early detection and quantification of Coxiella burnetii as an alternative to the murine bioassay. Molecular and Cellular Probes. 23(3-4). 127–131. 22 indexed citations
8.
Lowe, John R., Jihong Yang, Valerie Quarmby, et al.. (2007). Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo. Experimental Eye Research. 85(4). 425–430. 135 indexed citations
9.
Haughney, Peter C., John R. Lowe, Jeriza Rusit, et al.. (2005). Clinical Pharmacokinetics of Ranibizumab (LucentisTM) in Subjects With AMD. Investigative Ophthalmology & Visual Science. 46(13). 1383–1383. 7 indexed citations
10.
Lowe, John R., João R. Araújo, Michele De Palma, et al.. (2003). RhuFab V2 Inhibits VEGF-Isoforms-Stimulated HUVEC Proliferation. Investigative Ophthalmology & Visual Science. 44(13). 1828–1828. 3 indexed citations
11.
Xiang, Hong, Judith A. Fox, Klára Tótpál, et al.. (2002). Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors. Oncogene. 21(22). 3611–3619. 45 indexed citations
12.
Lowe, John R., et al.. (1995). Allergen-induced histamine release in rat mast cells transfected with the α subunits of FcεRI. Journal of Immunological Methods. 184(1). 113–122. 17 indexed citations
13.
Fei, David T.W., John R. Lowe, & Paula Jardieu. (1994). A novel bioactivity assay for monoclonal antibodies directed against IgE. Journal of Immunological Methods. 171(2). 189–199. 7 indexed citations
14.
Hutson, Roger A., Clive J. Duggleby, John R. Lowe, R.J. Manchee, & P. C. B. Turnbull. (1993). The development and assessment of DNA and oligonucleotide probes for the specific detection of Bacillus anthracis. Journal of Applied Bacteriology. 75(5). 463–472. 20 indexed citations
15.
Little, Stephen F. & John R. Lowe. (1991). Location of receptor-binding region of protective antigen from Bacillusanthracis. Biochemical and Biophysical Research Communications. 180(2). 531–537. 14 indexed citations
16.
Bella, I.R., et al.. (1989). Comparison of Steady‐State Blood Levels of Two Carbamazepine Formulations. Epilepsia. 30(1). 67–70. 34 indexed citations
17.
Welkos, Susan L., et al.. (1988). Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene. 69(2). 287–300. 130 indexed citations
18.
Lieske, Claire N., et al.. (1984). Eel acetylcholinesterase inhibition studies with heteroarylphosphinates. Pesticide Biochemistry and Physiology. 22(3). 285–294. 7 indexed citations
19.
Lieske, Claire N., James H. Clark, Howard G. Meyer, & John R. Lowe. (1980). Spontaneous and induced reactivation of eel acetylcholinesterase inhibited by three organophosphinates. Pesticide Biochemistry and Physiology. 13(3). 205–212. 21 indexed citations
20.
Lieske, Claire N., et al.. (1978). Phosphinate inhibition studies of cholinesterases. Pesticide Science. 9(2). 135–138. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ten‐Yang Yen Breakdown of academic impact, for papers by Allan Rosenthal Breakdown of academic impact, for papers by Michael E. Hudson Breakdown of academic impact, for papers by Brandi Levin Breakdown of academic impact, for papers by T D Heath Breakdown of academic impact, for papers by Mireille Cartier Breakdown of academic impact, for papers by Anna Lucia Tornesello Breakdown of academic impact, for papers by Raquel García-Castellanos Breakdown of academic impact, for papers by Theodoros Goulas Breakdown of academic impact, for papers by Vanesa Olivares‐Illana
Rankless by CCL
2026